Discontinued — last reported Q4 '22
Researchandmedicalproducts — Sales
Danaher Researchandmedicalproducts — Sales remained flat by 0.0% to $6.66B in Q4 2022 compared to the prior quarter. Year-over-year, this metric grew by 7.4%, from $6.20B to $6.66B. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase indicates growing demand for the company's scientific and medical technologies, while a decrease may signal market saturation or competitive pressure in the life sciences sector.
Detailed definition
This metric represents the total revenue generated from the sale of scientific instruments, laboratory equipment, and me...
Peer comparison
Comparable to revenue segments in life science tools and diagnostics companies, such as those reported by Thermo Fisher Scientific or Agilent Technologies.
dhr_segment_research_and_medical_products_salesHistorical Data
| FY'21 | FY'22 | |
|---|---|---|
| Value | $24.80B | $26.64B |
| YoY Change | — | +7.4% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Danaher's researchandmedicalproducts — sales?
- Danaher (DHR) reported researchandmedicalproducts — sales of $6.66B in Q4 2022.
- How has Danaher's researchandmedicalproducts — sales changed year-over-year?
- Danaher's researchandmedicalproducts — sales increased by 7.4% year-over-year, from $6.20B to $6.66B.
- What does researchandmedicalproducts — sales mean?
- Total revenue earned from selling scientific research tools and medical diagnostic products.